tigermedgrp.com
Open in
urlscan Pro
71.172.119.77
Public Scan
Submitted URL: http://tigermedgrp.com/
Effective URL: https://tigermedgrp.com/en/homepage
Submission: On October 05 via manual from GB — Scanned from GB
Effective URL: https://tigermedgrp.com/en/homepage
Submission: On October 05 via manual from GB — Scanned from GB
Form analysis 1 forms found in the DOM
<form x-data="searchJobsForm()" @submit.prevent="submitData">
<div class="grid grid-cols-1 gap-3 md:grid-cols-2">
<div class="">
<input type="text" id="name" x-model="formData.name" class="bg-white rounded-full w-full pl-5 text-gray-tigermed-dark ring-0 ring-white border border-white focus:border-white focus:ring-0 focus:ring-white placeholder-gray-300"
placeholder="Name" required="">
</div>
<div class="">
<input type="text" id="company" x-model="formData.company" class="bg-white rounded-full w-full pl-5 text-gray-tigermed-dark ring-0 ring-white border border-white focus:border-white focus:ring-0 focus:ring-white placeholder-gray-300"
placeholder="Your Company" required="">
</div>
<div class="">
<input type="text" id="country" x-model="formData.country" class="bg-white rounded-full w-full pl-5 text-gray-tigermed-dark placeb ring-0 ring-white border border-white focus:border-white focus:ring-0 focus:ring-white placeholder-gray-300"
placeholder="Country" required="">
</div>
<div class="">
<input type="email" id="email_address" x-model="formData.email_address"
class="bg-white rounded-full w-full pl-5 text-gray-tigermed-dark ring-0 ring-white border border-white focus:border-white focus:ring-0 focus:ring-white placeholder-gray-300" placeholder="Email address" required="">
</div>
</div>
<div class="flex items-start pt-3">
<div class="flex items-center h-5">
<input id="check_yes" x-model="formData.check_yes" type="checkbox" value="" class="w-4 h-4 border bg-green-tigermed border-gray-300 rounded-full focus:ring-3 focus:ring-green-tigermed accent-green-tigermed" checked="">
</div>
<label for="check_yes" class="ml-2 tigermed-text-context-xs text-white mt-0"> Yes, I would like to opt in to receive email communications from Tigermed. </label>
</div>
<div class="pt-3">
<p x-text="message"></p>
<button type="submit"
class="ring-green-tigermed border border-white px-10 py-2.5 text-white hover:text-green-tigermed bg-green-tigermed hover:bg-white text-bg focus:ring-4 focus:outline-none font-medium rounded-full text-sm w-full sm:w-auto zh text-center">Subscribe</button>
</div>
<div class="flex items-start pt-3">
<label for="check_yes" class="ml-2 tigermed-text-context-xxs text-white mt-0 italic">By submitting this form, you agree to our Privacy Policy, and Tigermed will process the personal data you submit to us during the enquiry process according to
Tigermed Privacy Policy. </label>
</div>
</form>Text Content
About Tigermed
Our Company
Culture & Values
Leadership
Global Locations
Corporate Compliance
Subsidiaries & Joint Ventures
Diversity & Inclusion
Media & Resources
Press Releases
Events
Tigermed Insights
Resource Library
ESG
Sustainability & ESG Report
ESG Management
Corporate Responsibility
Corporate Video
We are committed to supporting our clients in their clinical development in the
best possible way.
By Phase
Preclinical
Early Phase
Phase II-III Clinical
Post-Marketing
Real World Study
Preclinical Development
Medicinal Chemistry
Compound Screening
DMPK
Safety & Toxicology
Bioanalytical
CMC
Clinical Development
Medical Writing
Clinical Monitoring
Regulatory Affairs
Data Management and Statistical Analysis
Clinical Development Strategy
Site Management (SMO)
Subject Recruitment
Medical Device / IVD
Multi-region Clinical Trial (MRCT)
Vaccine Clinical Trial
Integrated Capabilities
Medical Imaging
Pharmacovigilance
Medical Translation
Quality Assurance
GMP Consulting
Central Laboratories
Functional Service Provider (FSP)
EDC System
Call Center
Therapeutic Expertise
Oncology
Infectious Diseases
Hematology
Cardiovascular
Endocrinology
Rheumatology
Central Nervous System
Gastroenterology
Ophthalmology
Careers
Talent Development
Enjoy Your Life with Tigermed
Join Tigermed
Global Locations
Discover our offices across Asia, US, Europe, Latin America and Africa.
Career Opportunities
Explore your career opportunities worldwide with Tigermed.
Investors
Corporate Governance
Financial Reports & Presentations
Announcements
Prospectus
Investor Contact
Tigermed 2023 Interim Results Presentation
View Tigermed 2023 Interim Results Presentation
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
Contact
Business Enquiry / RFP
Media & Investors Enquiry
Compliance Concern
Give Us Your Feedback
Business Enquiry / RFP
Let us know how we can help with your healthcare innovation.
Media & Investors Enquiry
Submit media or investor related enquiries to us.
QUICK LINKS
Preclinical
Early Phase
Phase II-III Clinical
Post-Marketing
Real World Study
简 繁
About Tigermed
* About Tigermed
* Our Company
* Culture & Values
* Leadership
* Global Locations
* Corporate Compliance
* Subsidiaries & Joint Ventures
* Diversity & Inclusion
* ESG
* Sustainability & ESG Report
* ESG Management
* Corporate Responsibility
* Media & Resources
* Press Releases
* Events
* Tigermed Insights
* Resource Library
Solutions
* By Phase
* Preclinical
* Early Phase
* Phase II-III Clinical
* Post-Marketing
* Real World Study
* Preclinical Development
* Medicinal Chemistry
* Compound Screening
* DMPK
* Safety & Toxicology
* Bioanalytical
* CMC
* Clinical Development
* Medical Writing
* Clinical Monitoring
* Regulatory Affairs
* Data Management and Statistical Analysis
* Clinical Development Strategy
* Site Management (SMO)
* Subject Recruitment
* Medical Device / IVD
* Multi-region Clinical Trial (MRCT)
* Vaccine Clinical Trial
* Integrated Capabilities
* Medical Imaging
* Pharmacovigilance
* Medical Translation
* Quality Assurance
* GMP Consulting
* Central Laboratories
* Functional Service Provider (FSP)
* EDC System
* Call Center
* Therapeutic Expertise
* Oncology
* Infectious Diseases
* Hematology
* Cardiovascular
* Endocrinology
* Rheumatology
* Central Nervous System
* Gastroenterology
* Ophthalmology
Careers
* Talent Development
* Enjoy Your Life with Tigermed
* Join Tigermed
Investors
* Corporate Governance
* Financial Reports & Presentations
* Announcements
* Prospectus
* Investor Contact
Contact
* Business Enquiry / RFP
* Media & Investors Enquiry
* Compliance Concern
* Give Us Your Feedback
About Solutions Careers Investors Contact
简 繁
Tigermed
Advance Human Health through Delivery Excellence
Learn More
Tigermed
A Leading CRO with Global Reach and Proven Expertise
Learn More
Tigermed
Sharing Knowledge for Better Research
Learn More
Tigermed
Advance Human Health through Delivery Excellence
Learn More
Tigermed
A Leading CRO with Global Reach and Proven Expertise
Learn More
ENABLING LIFE-CHANGING THERAPIES WITH
EXCELLENCE AND COMMITMENT
Learn more
Global Employees 10,000+
Global Customers 2,800+
Global Offices and Locations 180+
Innovative Drugs Supported 92
Your browser does not support the video tag.
A FULL SUITE OF CRO CAPABILITIES
Integrated Platform with End-to-End Services
* Development Services_2
* Manufacturing Services_2
* Analytical Services
* Analytical Services
Preclinical
Development
Your Partner for Preclinical Research and Development with One-Stop Platform and
Solutions.
Learn More Clinical
Development
Providing flexible approach and end-to-end clinical services to support global
advance of life-saving therapies.
Learn More Integrated
Services
Leveraging our top-notch technology and platform to improve clinical study
outcomes.
Learn More Real World
Study
Maximize the value of your product through real world data and innovative
approaches.
Learn More
Preclinical Development
Learn More
Clinical Development
Learn More
Integrated Services
Learn More
Real World Study
Learn More
Tigermed Insights
Sharing Knowledge for Better Research
Show more
At Tigermed, we believe knowledge needs to be shared to further develop clinical
programs, increase market access, and to meet unmet patients needs.
The 2021 Drug Review Annual Report
Read more
Clinical Trials Ultimately Aim to Improve Human Health
Read more
Clinical value is top priority in cancer drug trials, CDE says.
Read more
STAY CONNECTED WITH TIGERMED
Sign up to receive our newsletter on hands-on expertise, industry news, changing
legislation and tips on practical solutions to industry challenges.
Yes, I would like to opt in to receive email communications from Tigermed.
Subscribe
By submitting this form, you agree to our Privacy Policy, and Tigermed will
process the personal data you submit to us during the enquiry process according
to Tigermed Privacy Policy.
About
* About Tigermed
* Environment, ESG
* Media and Resources
Solutions
* By Phase
* Preclinical Development
* Clinical Development
* Integrated Capabilities
* Therapeutic Expertise
Careers
* Talent Development
* Enjoy Your Life with Tigermed
* Join Tigermed
Investors
* Corporate Governance
* Financial Reports and Presentations
* Announcements
* Prospectus
* Investor Contact
Contact
* Business Enquiry / RFP
* Media & Investors Enquiry
* Compliance Concern
* Give Us Your Feedback
FOOTER
ABOUT
* Our Company
* Leadership
* Global Locations
* Press Releases
* Events
SOLUTIONS
* Preclinical
* Early Phase
* Phase II-III Clinical
* Post-Marketing
* Real World Study
CAREERS
* Talent Development
* Enjoy Your Life with Tigermed
* Join Tigermed
INVESTORS
* Corporate Governance
* Financial Reports and Presentations
* Announcements
* Prospectus
* Investor Contact
CONTACT
* Business Enquiry / RFP
* Media & Investors Enquiry
* Compliance Concern
* Give Us Your Feedback
Global Headquarters
F 18, Building A – Shengda Science Park, No.19 Jugong Road, Binjiang District,
Hangzhou, China 310051
Tel: +86-571-28887227
Copyright © 2004- 2023 Tigermed All Rights Reserved. 浙 ICP 备 11043991 号 - 7
浙公网安备 33010802012949 号
Cookies Privacy Policy Terms of Use
Cookies
The site uses cookies in order to collect data to provide general statistics to
optimize site functionality and offer you a better experience. For more
information, visit our Privacy Policy.
Reject All Accept All
Contact us
Business Enquiry / RFP
Media & Investors Enquiry
Compliance Concern
Give Us Your Feedback